Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023 We have seen major advances in prostate cancer research, and people with the disease are living longer than ever. However, more needs to be done to harness scientific discoveries and bring innovative drugs to patients. Here we discuss the regulatory landscape and reforms needed to ensure patients can access the most innovative treatments as quickly as possible. Find out more Show/Hide
Access routes and asking prices - getting drugs to cancer patients 11 Nov 2020 Today the ICR and 15 organisations launch a nine point plan on cancer drug pricing and access. Here, our Policy Officer Joanne Duffy speaks to patient advocate Emma Robertson about the recommendations. Find out more Show/Hide
What’s coming for cancer in the 2020s 23 Jan 2020 We’ve learned a lot about cancer in the last decade, with survival rates better now than ever before. Our Policy Adviser, Roya Ziaie, takes a look at what might be in store over the next ten years in an ever-changing field. Find out more Show/Hide
Investing in the future – what does the life sciences sector deal mean for cancer research? 08 Dec 2017